{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:56Z","timestamp":1761919496282},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,11,25]],"date-time":"2011-11-25T00:00:00Z","timestamp":1322179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10072-011-0848-1","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T10:48:01Z","timestamp":1322131681000},"page":"863-867","source":"Crossref","is-referenced-by-count":9,"title":["Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"33","author":[{"given":"Marco","family":"Capobianco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Motuzova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Frau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mamusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,25]]},"reference":[{"key":"848_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1191\/135248506ms1256oa","volume":"12","author":"M Daumer","year":"2006","unstructured":"Daumer M, Griffith LM, Meister W, Nash RA, Wolinsky JS (2006) Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation. Mult Scler 12:174\u2013179","journal-title":"Mult Scler"},{"key":"848_CR2","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1073\/pnas.82.8.2483","volume":"82","author":"S Ikehara","year":"1985","unstructured":"Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo Mm, Muso E, Ogawa K, Hamashima Y (1985) Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 82:2483\u20132487","journal-title":"Proc Natl Acad Sci USA"},{"key":"848_CR3","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1073\/pnas.86.24.10090","volume":"86","author":"DW Bekkum van","year":"1989","unstructured":"van Bekkum DW, Bohre EP, Houben PF, Knaan-Shanzer S (1989) Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 86:10090\u201310094","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"848_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/WCO.0b013e328338b7ed","volume":"23","author":"A Uccelli","year":"2010","unstructured":"Uccelli A, Mancardi G (2010) Stem cell transplantation in multiple sclerosis. Curr Opin Neurol 23(3):218\u2013225","journal-title":"Curr Opin Neurol"},{"key":"848_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(08)70138-8","volume":"7","author":"G Mancardi","year":"2008","unstructured":"Mancardi G, Saccardi R (2008) Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 7:626\u2013636","journal-title":"Lancet Neurol"},{"key":"848_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.57.1.62","volume":"57","author":"GL Mancardi","year":"2001","unstructured":"Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese M, Marrosu MG, Meucci G, Massacesi L, Lugaresi A, Pagliai F, Sormani MP, Sardanelli F, Marmont A (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57:62\u201368","journal-title":"Neurology"},{"key":"848_CR7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood-2004-08-3205","volume":"105","author":"R Saccardi","year":"2005","unstructured":"Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM (2005) Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 105:2601\u20132607","journal-title":"Blood"},{"issue":"3","key":"848_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/10428190902756578","volume":"50","author":"T Seshadri","year":"2009","unstructured":"Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M (2009) Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma 50(3):380\u2013386","journal-title":"Leuk Lymphoma"},{"key":"848_CR9","unstructured":"Mancardi GL (2008) Light trial. EUDRA CT number n2006-002562-19. http:\/\/eudract.emea.europa.eu . Accessed 29 May 2008"},{"key":"848_CR10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(09)70021-3","volume":"8","author":"E Havrdova","year":"2009","unstructured":"Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, O\u2019Connor PW, Giovannoni G, Phillips JT, Lublin FD, Pace A, Kim R, Hyde R (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the natalizumab safety and efficacy in relapsing-remitting multiple sclerosis (AFFIRM) study. Lancet Neurol 8:254\u2013260","journal-title":"Lancet Neurol"},{"key":"848_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/IJGM.S13648","volume":"3","author":"A Mouzaki","year":"2010","unstructured":"Mouzaki A, Koutsokera M, Dervilli Z, Rodi M, Kalavrizioti D, Dimisianos N, Matsoukas I, Papathanasopoulos P (2010) Remitting-relapsing multiple sclwerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab. Int J Gen Med 3:313\u2013320","journal-title":"Int J Gen Med"},{"issue":"1\u20132","key":"848_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jneuroim.2007.04.006","volume":"187","author":"R Gold","year":"2007","unstructured":"Gold R, Jawad A, Miller DH, Henderson DC, Fassas A, Fierz V, Hartung HP (2007) Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. J Neuroimmunol 187(1\u20132):156\u2013158","journal-title":"J Neuroimmunol"},{"issue":"12","key":"848_CR13","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.leu.2404443","volume":"20","author":"A Ledda","year":"2006","unstructured":"Ledda A, Caocci G, Spinicci G, Cocco E, Mamusa E, La Nasa G (2006) Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis. Leukemia 20(12):2217\u20132218","journal-title":"Leukemia"},{"key":"848_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose J, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Voltarelli JC, Burns WH (2009) Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study. Lancet Neurol 8:244\u2013253","journal-title":"Lancet Neurol"},{"key":"848_CR15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/1352458508092810","volume":"14","author":"D Centonze","year":"2008","unstructured":"Centonze D, Furlan R, Gasperini C, Salvetti M, Battistini L (2008) Early relapses after the first dose of natalizumab in active multiple sclerosis patients. Multiple Sclerosis 14:1137\u20131138","journal-title":"Multiple Sclerosis"},{"key":"848_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2005.12.003","volume":"27","author":"PA Muraro","year":"2006","unstructured":"Muraro PA, Douek DC (2006) Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol 27:61\u201367","journal-title":"Trends Immunol"},{"key":"848_CR17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M, Meinl I, Kumpfle T, Hohlfeld R, Meinl E (2008) Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350\u20131354","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-011-0848-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0848-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:19:37Z","timestamp":1559121577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-011-0848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,25]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1007\/s10072-011-0848-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,25]]}}}